cariporide has been researched along with cangrelor in 2 studies
| Studies (cariporide) | Trials (cariporide) | Recent Studies (post-2010) (cariporide) | Studies (cangrelor) | Trials (cangrelor) | Recent Studies (post-2010) (cangrelor) |
|---|---|---|---|---|---|
| 409 | 10 | 79 | 418 | 54 | 286 |
| Protein | Taxonomy | cariporide (IC50) | cangrelor (IC50) |
|---|---|---|---|
| Ornithine decarboxylase | Rattus norvegicus (Norway rat) | 0.0004 | |
| P2Y purinoceptor 12 | Homo sapiens (human) | 0.0043 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harder, S; Klinkhardt, U; Kuczka, K | 1 |
| Alhammouri, A; Cohen, MV; Cui, L; Downey, JM; Yang, XM | 1 |
2 other study(ies) available for cariporide and cangrelor
| Article | Year |
|---|---|
Effects of the NHE-1 inhibitor cariporide alone or together with the P2Y12 antagonist AR-C 69331 MX on CD62p expression and formation of platelet-leukocyte aggregates.
Topics: Adenosine Monophosphate; Blood Platelets; Cell Aggregation; Cells, Cultured; Dose-Response Relationship, Drug; Drug Combinations; Guanidines; Humans; Leukocytes; Membrane Proteins; Neutrophil Activation; Osmosis; P-Selectin; Platelet Aggregation; Purinergic P2 Receptor Antagonists; Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide; Receptors, Pituitary Hormone; Receptors, Purinergic P2Y12; Sodium-Hydrogen Exchangers; Sulfones | 2003 |
Triple therapy greatly increases myocardial salvage during ischemia/reperfusion in the in situ rat heart.
Topics: Adenosine; Adenosine Monophosphate; Animals; Anti-Arrhythmia Agents; Cardiotonic Agents; Guanidines; Hypothermia, Induced; Ischemic Preconditioning, Myocardial; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Purinergic P2Y Receptor Antagonists; Rats; Rats, Sprague-Dawley; Sulfones; Ticagrelor | 2013 |